Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 6
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Management of Crohn Disease: A Review.
Cushing K, Higgins PDR. Cushing K, et al. JAMA. 2021 Jan 5;325(1):69-80. doi: 10.1001/jama.2020.18936. JAMA. 2021. PMID: 33399844 Free PMC article. Review.
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Berinstein JA, et al. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2112-2120.e1. doi: 10.1016/j.cgh.2021.05.038. Epub 2021 May 25. Clin Gastroenterol Hepatol. 2021. PMID: 34048936 Free PMC article.
Management of Crohn Disease-Reply.
Cushing K, Higgins PDR. Cushing K, et al. JAMA. 2021 May 4;325(17):1794-1795. doi: 10.1001/jama.2021.2921. JAMA. 2021. PMID: 33944877 No abstract available.
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.
Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Steiner CA, et al. Clin Gastroenterol Hepatol. 2022 Apr;20(4):817-846.e10. doi: 10.1016/j.cgh.2021.05.054. Epub 2021 Jun 2. Clin Gastroenterol Hepatol. 2022. PMID: 34089850 Free PMC article.
Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives.
Sheehan JL, Greene-Higgs L, Swanson L, Higgins PDR, Krein SL, Waljee AK, Saini SD, Berinstein JA, Mellinger JL, Piette JD, Resnicow K, Cohen-Mekelburg S. Sheehan JL, et al. Clin Transl Gastroenterol. 2023 Jun 1;14(6):e00577. doi: 10.14309/ctg.0000000000000577. Clin Transl Gastroenterol. 2023. PMID: 36881812 Free PMC article.
Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panés J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; International Organization for Inflammatory Bowel Disease Fibrosis Working Group. D'Haens G, et al. Gastroenterology. 2022 Jan;162(1):26-31. doi: 10.1053/j.gastro.2019.05.072. Epub 2019 Jun 27. Gastroenterology. 2022. PMID: 31254502 Free PMC article.
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients.
Higgins PDR, Ng S, Danese S, Rao K. Higgins PDR, et al. Crohns Colitis 360. 2020 Apr;2(2):otaa026. doi: 10.1093/crocol/otaa026. Epub 2020 Apr 16. Crohns Colitis 360. 2020. PMID: 32377636 Free PMC article.
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR, Higgins PDR. Steiner CA, et al. Inflamm Bowel Dis. 2021 Feb 16;27(3):303-316. doi: 10.1093/ibd/izaa169. Inflamm Bowel Dis. 2021. PMID: 32676663 Free PMC article.
15 results